Fundamental dimension Equity attribute | AURWFLeader $0.150.00% Cap $174.4KP/E -11.0x QuantScore39/100 | CBBLFPeer $0.080.00% Cap $6.17MP/E -29.4x QuantScore28/100 | CMTNFPeer $0.10470.00% Cap $343.9KP/E — QuantScore17/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
45/100 |
53/100 |
36/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 26/100 | 25/100 | 0/100 |
Growth Revenue / earnings growth & margins | 50/100 | 0/100 | 34/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -11.0x | -29.4x | — |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -14.8x | -67.2x | — |
Price / Sales | — | — | — |
Price / Free Cash Flow | -30.3x | -483.3x | — |
PEG ratio | 0.03 | 0.16 | — |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | -14.30 (Distress) | -75.72 (Distress) | -95.70 (Distress) |
Total debt / equity | 0.00 | -0.07 | — |
Quick ratio | 0.8x | 0.2x | — |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | — |
Net income growth YoY | +216.5% | -730.1% | +10.2% |
Gross margin (TTM) | 0.0% | 0.0% | — |
Operating margin (FY) | — | — | — |
FCF margin (FY) | — | — | — |
5. Trailing price performancePrice change over period |
1M return | 0.0% | 0.0% | -5.8% |
3M return | -46.4% | +83.1% | -65.5% |
6M return | -46.4% | +153.2% | -62.7% |
Year to date | -31.8% | +247.8% | +22.9% |
1Y return | -92.5% | +6566.7% | -19.5% |
3Y return | -85.0% | +700.0% | -86.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-0.115 -176.6% premium | $-0.0008 -101.0% premium | $0.0124 -88.2% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |